EVALUASI PENGGUNAAN OBAT ANTIHIPERTENSI PADA PASIEN RAWAT JALAN DI RUMAH SAKIT EFARINA ETAHAM KOTA PEMATANGSIANTAR PERIODE APRIL - JUNI TAHUN 2024
Keywords:
Hypertension, Antihypertension, RationalityAbstract
Hypertension is an increase in systolic blood pressure of more than equal to 140 mmHg and diastolic blood pressure of more than equal to 90 mmHg (Ministry of Health, 2021). Data from the World Health Organization (WHO) states that hypertension is one of the causes of premature death throughout the world. By 2020 around 1.56 billion adults will be living with hypertension. The World Health Organization (WHO) notes that currently the global prevalence of hypertension is 22% of the world's total population. This study aims to broadcast the use of hypertension medication in patients at the Efarina Etaham Hospital, Pematangsiantar City for the period April-June 2024. Based on five indicators, namely the right indication, the right patient, the right drug, the right dose, the right duration of drug administration. create systematic, factual and accurate descriptions of images, or paintings regarding the facts, characteristics and relationships between the phenomena being marketed (Savira & Suharsono, 2019). This research was conducted on 80 medical records with a diagnosis of hypertension with or without comorbidities who received antihypertensive medication for the period April-June 2024. The results of the study showed that the appropriate evaluation of the use of antihypertensive medication was obtained, namely 100% correct indication, 100% correct patient, 100% correct medication. of 100% and the correct dose is 100%.
References
Arizka, N. (2021). arti Polifarmasi
Choirunnasihin. (2019). prevelensi hipertensi di sumut 2019. Jurnal Ilmiah, 10(2), 1–94.
Dong, Z. (2012). faktor hipertensi yg tidak dpt di ubah. Экономика Региона, Kolisch 1996, 49–56.
Fauziah, H., Mulyana, R., & Martini, R. D. (2020). Polifarmasi Pada Pasien Geriatri. Human CareJournal,5(3),804.
Hasanah, U. (2019). pengertian Hipertensi. Jurnal Keperawatan Jiwa, 7(1), 87..
Kemenkes. (2021). menkes 2021Tata Laksana Hipertensi Dewasa. Kementerian Kesehatan RI, 1–85.
Lailiyah, A. (2019). obat adalah. Skripsi. Universitas Muhammadiyah Gresik, 3– 16.
Mathematics, A. (2016). kesehatan latar blkng. 1–23.
Menkes RI. (2016). standar pelayanan rumah sakit. Nature Methods, 7(6), 2016.
Muji Lestari, R., Ningsih, F., Studi Sarjana Kesehatan Masyarakat, P., Eka Harap, S., Raya, P., & Tengah, K. (2022). Hubungan Gaya Hidup (Lifestyle) Dengan Kejadian Hipertensi Pada Usia Produktif The Relationship Of Lifestyle With Hypertension In Productive Age. Jurnal Surya Medika, 1–7. http://journal.umpalangkaraya.ac.id/index.php/jsm.
Musa, E. C. (2022). Hipertensi terbanyak di benua. Sam Ratulangi Journal of Public Health, 2(2), 060.
Menkes RI. (2016). standar pelayanan rumah sakit. Nature Methods, 7(6), 2016.Novelly Milla. (2019). hipertensi jnc viii.
Savira, F., & Suharsono, Y. (2019). Metode Penelitian. Journal of Chemical Information and Modeling, 01(01), 1689–1699.
Sitorus, J. (2018). Hipertensi di toba. Universitas Sumatera Utara, 1(3), 82–91. Sutarga, i made. (2017). Hipertensi s ilent killer. HIPERTENSI DAN PENATALAKSANAANNYA Oleh Dr . I Made Sutarga , M . Kes Program Studi Kesehatan Masyarakat Fakultas Kedokteran UniversitasUdayana . 10–22., 10–22.
Tjay, T. H., & Rahardja, K. (2015). tjai obat hipertensi. In PT Elex Media Komputindo (Vol. 53, Issue 9).
Tumanggor, S. D., Penelitian, A., Tumanggor, S. D., Aktalina, L., Yusria, A., Ismail, W. M., & Artikel, H. (2022). Hipertensi no 4 di sumut. Jurnal Kedokteran STM (Sains Dan Teknologi Medik), V(Ii), 174–180.
